Adaptive Biotechnologies Corp — Director's Dealing 2020

Dec 17, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Adaptive Biotechnologies Corp (ADPT)
CIK: 0001478320
Period of Report: 2020-12-14

Reporting Person: HILL NANCY LOUISE (EVP, Operations & Program Mana)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-12-14	Common Stock	M	40000	$0.84	Acquired	50000	Direct
2020-12-14	Common Stock	S	40000	$59.00	Disposed	10000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-12-14	Stock Option (Right to Buy)	$0.84	M	40000	Disposed	2023-11-03	Common Stock (40000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	500	Indirect
Common Stock	400	Indirect
Common Stock	300	Indirect

Footnotes

F1: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 21, 2020.

F2: The reporting person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein.

F3: The option is fully vested and exercisable.